Zhong WZ, Wang Q, Mao WM, Xu ST, et al. Gefitinib Versus Vinorelbine Plus Cisplatin as Adjuvant Treatment for Stage
II-IIIA (N1-N2) EGFR-Mutant NSCLC: Final Overall Survival Analysis of CTONG1104
Phase III Trial. J Clin Oncol 2021;39:713-722.
PMID: 33332190